Envestnet Asset Management Inc Crinetics Pharmaceuticals, Inc. Transaction History
Envestnet Asset Management Inc
- $299 Billion
- Q1 2025
A detailed history of Envestnet Asset Management Inc transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 56,691 shares of CRNX stock, worth $1.83 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,691
Previous 63,077
10.12%
Holding current value
$1.83 Million
Previous $3.23 Million
41.05%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CRNX
# of Institutions
235Shares Held
87MCall Options Held
40KPut Options Held
162K-
Vanguard Group Inc Valley Forge, PA9.31MShares$301 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.89MShares$223 Million0.05% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.24MShares$202 Million2.28% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$201 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.11MShares$165 Million0.02% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $1.74B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...